Quick Answer
Disc Medicine, Inc. reported Net Income of -$212.18 million for fiscal year 2025.
Disc Medicine, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$212.18M | -94.0% |
| 2024 | -$109.36M | -43.1% |
| 2023 | -$76.43M | -63.2% |
| 2022 | -$46.83M | -30.2% |
| 2021 | -$35.97M | +11.9% |
| 2020 | -$40.84M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$62.32M | -134.3% | -12.8% |
| June 30, 2025 | -$55.25M | -109.7% | -62.1% |
| March 31, 2025 | -$34.09M | -26.5% | -28.1% |
| September 30, 2024 | -$26.60M | -88.4% | -0.9% |
| June 30, 2024 | -$26.35M | -65.2% | +2.2% |
| March 31, 2024 | -$26.95M | -18.3% | -90.8% |
| September 30, 2023 | -$14.12M | +12.6% | +11.4% |
| June 30, 2023 | -$15.95M | -66.5% | +30.0% |
- Disc Medicine, Inc. showed a decrease of -94.0% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Disc Medicine, Inc.’s net income has declined by 419.6% (from -$40.84 million to -$212.18 million).
- The most recent figure is from Disc Medicine, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: